The decline in PSA levels in the latter half of RT is speculated to be attributable to tumor lysis [5, 10]; in our study, however, only 2 patients exhibited a decrease in the PSA level of 0.15 ng/mL or more during the first half of RT. The gene discussed is KLK3; the disease is neoplasm.